Annual Results Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
450.63
444.58
659.00
512.61
536.27
591.03
653.96
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
450.63
444.58
659.00
512.61
536.27
591.03
653.96
Raw Material Cost
359.74
322.69
402.29
370.33
360.92
302.23
325.04
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
100.80
99.75
92.88
85.92
73.48
71.78
65.78
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.51
0.53
0.58
0.57
0.37
2.51
4.27
Selling and Distribution Expenses
60.05
58.27
59.05
46.78
37.98
65.29
88.20
Other Expenses
-7.71
-6.87
-4.30
-6.78
-5.66
-5.21
-4.58
Total Expenditure (Excl Depreciation)
444.03
412.51
511.82
435.81
416.16
389.67
437.49
Operating Profit (PBDIT) excl Other Income
6.6000000000000005
32.1
147.20000000000002
76.8
120.1
201.4
216.5
Other Income
29.35
55.50
56.62
73.53
20.29
1.04
7.63
Operating Profit (PBDIT)
76.81
112.09
223.71
170.43
158.22
219.33
244.46
Interest
0.51
0.53
0.58
0.57
0.37
2.51
4.27
Exceptional Items
8.62
14.58
1.44
-0.66
0.70
0.00
-1.44
Gross Profit (PBDT)
90.90
121.89
256.71
142.28
175.35
288.79
328.92
Depreciation
43.66
25.72
21.76
21.76
19.37
18.19
21.76
Profit Before Tax
41.26
100.42
202.82
147.44
139.18
198.63
217.00
Tax
6.35
8.87
26.70
21.65
17.54
30.56
32.38
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
34.91
91.55
176.12
125.79
121.65
168.07
100.29
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
34.91
91.55
176.12
125.79
121.65
168.07
100.29
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
84.33
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
34.91
91.55
176.12
125.79
121.65
168.07
184.62
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
0.0
0.0
Reserves
2,273.23
2,309.69
2,356.68
2,276.57
2,222.78
700.39
488.25
Earnings per share (EPS)
0.08
0.22
0.42
0.3
0.29
0.4
0.24
Diluted Earnings per share
0.08
0.22
0.42
0.3
0.29
0.4
0.24
Operating Profit Margin (Excl OI)
0.84%
6.95%
22.05%
14.66%
22.11%
33.86%
32.89%
Gross Profit Margin
18.84%
28.37%
34.08%
33.01%
29.57%
36.69%
36.51%
PAT Margin
7.75%
20.59%
26.72%
24.54%
22.68%
28.44%
15.34%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Dec 2025 is 1.35% vs -32.53% in Dec 2024
Consolidate Net Profit
YoY Growth in year ended Dec 2025 is -61.86% vs -48.04% in Dec 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Dec 2025 is -16.08% vs -66.13% in Dec 2024
Interest
YoY Growth in year ended Dec 2025 is 0.00% vs -16.67% in Dec 2024
Operating Profit Margin (Excl OI)
YoY Growth in year ended Dec 2025 has fallen from Dec 2024
Compare Annual Results Of Hubei Biocause Heilen Pharmaceutical Co., Ltd. With
Figures in Million
Consolidate Annual Results
Change(CNY)
Change(%)
Net Sales
450.63
0
450.63
Other Operating Income
0.00
0.00
0.00
Total Operating income
450.63
0
450.63
Raw Material Cost
359.74
0
359.74
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
100.80
0
100.80
Power Cost
0
0
0.00
Manufacturing Expenses
0.51
0
0.51
Selling and Distribution Expenses
60.05
0
60.05
Other Expenses
-7.71
0.00
-7.71
Total Expenditure (Excl Depreciation)
444.03
0
444.03
Operating Profit (PBDIT) excl Other Income
6.60
0.00
6.60
Other Income
29.35
0
29.35
Operating Profit (PBDIT)
76.81
0
76.81
Interest
0.51
0
0.51
Exceptional Items
8.62
0
8.62
Gross Profit (PBDT)
90.90
0
90.90
Depreciation
43.66
0
43.66
Profit Before Tax
41.26
0
41.26
Tax
6.35
0
6.35
Provisions and contingencies
0
0
0.00
Profit After Tax
34.91
0
34.91
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
34.91
0
34.91
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
34.91
0
34.91
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
2,273.23
0
2,273.23
Earnings per share (EPS)
0.08
0
0.08
Diluted Earnings per share
0.08
0
0.08
Operating Profit Margin (Excl OI)
0.84%
0%
0.00
0.84%
Gross Profit Margin
18.84%
0%
0.00
18.84%
PAT Margin
7.75%
0%
0.00
7.75%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 45.06 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 1.35% vs -32.53% in Dec 2024
Annual - Consolidate Net Profit
Consolidate Net Profit 3.49 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is -61.86% vs -48.04% in Dec 2024
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 4.75 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is -16.08% vs -66.13% in Dec 2024
Annual - Interest
Interest 0.05 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 0.00% vs -16.67% in Dec 2024
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 0.84%
in Dec 2025Figures in %
YoY Growth in year ended Dec 2025 has fallen from Dec 2024
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
